SynthesisVeterinary medicine and science2025
A Comprehensive Systematic Review and Meta-Analysis on the Prevalence of Aflatoxin M1 in Dairy Products in Selected Middle East Countries.
Synthesis in Veterinary medicine and science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Aflatoxin M1 in Milk from South-Central and Northwest China: Prevalence and Integrated Risk Characterization for Different Age-Sex Groups of Consumers.Foods (Basel, Switzerland) · 2026Article
- Occurrence and health risk assessment of AFM1 in commercial yogurt in Thailand.Mycotoxin research · 2026Article
- Assessment of Cheese Contamination and Its Contribution to Aflatoxin M1 Intake in the Spanish Population.Foods (Basel, Switzerland) · 2026Article
- Decrease of AFMBrazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2025Article
- Review
- Aflatoxin Contamination in Agri-Food Systems: A Comprehensive Review of Toxicity, Food Security, Economic Impacts, and Sustainable Mitigation Across the Value Chain.Food science & nutrition · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundHuman consumption of dairy products contaminated with aflatoxin (AF) M1 can lead to severe health issues. This AF's significance and impact on health necessitate a thorough investigation of its prevalence in dairy products.
objectivesThis study aims to determine the prevalence of AFM1 in dairy products through a systematic review and meta-analysis, focusing on data from Middle Eastern countries.
methodsWe identified relevant studies through electronic database searches (PubMed, Scopus and Web of Science) up to August 2023. We employed a random-effects model to derive an overall estimate and used 95% confidence intervals to determine pooled prevalence rates.
resultsThe meta-analysis included 193 studies encompassing 297,530 samples of dairy products. The results showed that AFM1 contaminated 87% of dairy products. The following is a ranking of countries based on the prevalence of AFM1 in their dairy products: Iran > Jordan > Turkey > Kuwait > Lebanon > Syria > Egypt > Cyprus > the United Arab Emirates. The current meta-analysis indicated that Middle Eastern countries exhibited a high prevalence of AFM1 in dairy products. The prevalence rates for AFM1 in various dairy products were as follows: milk (87%), yogurt (68.9%), cheese (63.6%), kashk (62.9%), doogh (55.6%) and ice cream (54%). Pasteurized milk (99.5%), ultra-high temperature (91.3%), raw milk (73%) and traditional milk (51%), among other milk types, had the highest contamination rates.
conclusionThe study reveals a high prevalence of AFM1 in dairy products, particularly in Middle Eastern countries. Given the critical importance of milk and dairy products in the diet, special measures are needed to safeguard their quality and protect consumers from AF contamination.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.